NeuroFx
Fishers, US · Founded 2011 · Delaware corporation
Founders & leadership
WL
Wade LangeExecutive
JR
Jennifer RhodesExecutive
Board
BM
Brad MillerBoard director
SA
Scott A. JonesBoard director
KL
Keith L. MarchBoard director
Reported raises · per SEC filings
Form D private placements$1.9M disclosed across 2 rounds · 2016–2023
▶$28.5KraisedSep 2023 · 1 investors · BiotechnologyRule 506(c)
▶$28.5KraisedSep 2023 · 1 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Michael T RedmanExecutive Officer, Director
- Keith March MD PhDExecutive Officer, Director
- Brad T MillerDirector
- James Donald PayneExecutive Officer
- Michael Donald TrottaDirector
- Offering amount
- $950K
- Amount sold
- $28.5K
- Minimum investment
- $9.5K
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$1.9MraisedApr 2016 · 6 investors · BiotechnologyRule 506(b)
▶$1.9MraisedApr 2016 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brad MillerDirector
- Scott A. JonesDirector
- Wade LangeExecutive Officer
- Keith L. MarchDirector
- Jennifer RhodesExecutive Officer
- Offering amount
- $3.5M
- Amount sold
- $1.9M
- Minimum investment
- $40K
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has NeuroFx raised?
- NeuroFx has disclosed $1.9M raised across 2 rounds.
- Where is NeuroFx headquartered?
- NeuroFx is headquartered in Fishers, US.